Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Articles Tagged With: risks

  • Reduce Patient Safety Risks for ED Super-Utilizers

    Extreme ED super-utilizers pose significant risks and challenges for ED providers. Providers are at risk for missing signs of a serious condition because they have seen the patient in the ED so many times for the same complaint — whether back pain, headache, or abdominal pain.

  • Pfizer and Moderna Begin COVID-19 Vaccine Trials in Younger Children

    Both Pfizer-BioNTech and Moderna announced in March they had begun clinical trials of their COVID-19 vaccines in children younger than age 12 years. Although public reaction was mixed, researchers and bioethicists now say the timetable for a pediatric vaccine and for the United States to possibly reach herd immunity is early 2022.
  • Accounting for Patient Preference, Cardiovascular Disease Risk in Statin Therapy

    Researchers weighed patient preferences and risks regarding statin therapy after reviewing 10-year atherosclerotic cardiovascular disease risk scores.

  • Study of COVID-19 Vaccine in Pregnant People ‘Too Late’

    On Feb. 18, Pfizer and BioNTech announced they would dose about 4,000 healthy pregnant women with the COVID-19 vaccine to evaluate its safety, tolerability, and immunogenicity. Although pregnant people were excluded initially from the COVD-19 trials, research has shown they are at higher risk for more severe disease.

  • Study: Risk Assessment for Contraceptives Is Influenced by Cultural Biases

    Cultural assumptions create unbalanced risk assessment when the medical community weighs the risks and benefits of common contraceptive methods, the authors of a recent study concluded. Researchers studied contraception risks and assessed how these risks were prioritized in reproductive health providers’ understanding of contraceptives and their potential side effects.

  • Privacy Concerns with Telehealth Should Prompt Review

    With the use of telehealth increasing in response to the COVID-19 pandemic, there is growing concern the technology may pose risks to patient privacy. In particular, any telehealth services quickly established at the beginning of the pandemic may need a close review to ensure they do not result in data breaches.

  • Understanding Social Determinants of Health

    There is widespread acknowledgement that community-level social determinants — affordable housing, stable employment, reliable transportation, and access to healthy food — are a crucial component of holistic strategies to promote health, well-being, and longevity while also reducing healthcare costs. This month, we explore this concept and what it means for case management professionals, and most specifically social work case managers.

  • Actions for IRBs Reviewing Vaccine Challenge Trials

    As the world looks for a safe and effective vaccine against SARS-CoV-2, IRBs should review the bioethical implications of this type of study design, including assessing risks and benefits.

  • IRBs Can Prepare for Cannabis Research

    The cannabis industry is a booming economic force across the nation as states increasingly legalize the sale of medical and/or recreational marijuana. It remains on the national Schedule I list of drugs that are not acceptable for legal sale. But what do healthcare providers really understand about the drug’s safety, risks, and benefits? Not enough, human research protection professionals say.

  • Analysis Reveals Med/Mal Risks for Antibiotics Administered in ED

    Evidence on actual legal risks of failing to give antibiotics is lacking. Part of the problem is that both clinicians and patients frequently believe that taking an antibiotic is the safest practice in cases where it is unclear if antibiotics are needed.